References 1. Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. The Lancet Infectious Diseases. 2019;19(1):56-66. 2. Organisation for Economic Co-operation and Development, European Centre for Disease Prevention and Control. Antimicrobial Resistance. Tackling the Burden in the European Union. Briefing note for EU/EEA countries. Paris: Organisation for Economic Co-operation and Development; 2019. 3. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health careassociated infection and criteria for specific types of infections in the acute care setting. American Journal of Infection Control. 2008;36(5):309-32. 4. van der Schoor AS, Severin JA, van der Weg AS, Strepis N, Klaassen CHW, van den Akker JPC, et al. The effect of 100% single-occupancy rooms on acquisition of extended-spectrum betalactamase-producing Enterobacterales and intra-hospital patient transfers: a prospective before-andafter study. Antimicrob Resist Infect Control. 2022;11(1):76. 5. Voor In 't Holt AF, van der Schoor AS, Mourik K, Strepis N, Klaassen CHW, Vos MC, et al. PreCOVID-19 international travel and admission to hospital when back home: travel behavior, carriage of highly resistant microorganisms, and risk perception of patients admitted to a large tertiary care hospital. Antimicrob Resist Infect Control. 2022;11(1):78. 6. Arcilla MS, Van Hattem JM, Bootsma MCJ, van Genderen PJJ, Goorhuis A, Grobusch MP, et al. Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in a population of Dutch travellers: A cross-sectional study. Travel Medicine and Infectious Disease. 2020;33:101547. 7. Kluytmans-van den Bergh MFQ, van Mens SP, Haverkate MR, Bootsma MCJ, Kluytmans J, Bonten MJM, et al. Quantifying Hospital-Acquired Carriage of Extended-Spectrum Beta-LactamaseProducing Enterobacteriaceae Among Patients in Dutch Hospitals. Infect Control Hosp Epidemiol. 2018;39(1):32-9. 8. Rodríguez-Molina D, Berglund F, Blaak H, Flach CF, Kemper M, Marutescu L, et al. International Travel as a Risk Factor for Carriage of Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Large Sample of European Individuals-The AWARE Study. Int J Environ Res Public Health. 2022;19(8). 9. European Centre for Disease Prevention and Control. Surveillance Atlas of Infectious Diseases 2022 [Available from: https://atlas.ecdc.europa.eu/public/index.aspx, accessed on April 4, 2022]. 10. Weterings V, Veenemans J, van Rijen M, Kluytmans J. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus in patients at hospital admission in The Netherlands, 2010-2017: an observational study. Clin Microbiol Infect. 2019;25(11):1428 e1- e5. 11. Wertheim HFL, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus infections. The Lancet Infectious Diseases. 2005;5(12):751-62. 12. Hilty M, Betsch BY, Bögli-Stuber K, Heiniger N, Stadler M, Küffer M, et al. Transmission dynamics of extended-spectrum β-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis. 2012;55(7):967-75. 13. Tschudin-Sutter S, Frei R, Schwahn F, Tomic M, Conzelmann M, Stranden A, et al. Prospective Validation of Cessation of Contact Precautions for Extended-Spectrum β-LactamaseProducing Escherichia coli. Emerg Infect Dis. 2016;22(6):1094-7. 14. Tschudin-Sutter S, Frei R, Dangel M, Stranden A, Widmer AF. Rate of transmission of extended-spectrum beta-lactamase-producing enterobacteriaceae without contact isolation. Clin Infect Dis. 2012;55(11):1505-11. 200 Chapter 4
RkJQdWJsaXNoZXIy MTk4NDMw